首页> 外文期刊>Vascular pharmacology >Beneficial effect of pentaerythrityl tetranitrate on functional and morphological changes in the rat thoracic aorta evoked by long-term nitric oxide synthase inhibition.
【24h】

Beneficial effect of pentaerythrityl tetranitrate on functional and morphological changes in the rat thoracic aorta evoked by long-term nitric oxide synthase inhibition.

机译:季戊四醇四硝酸盐对长期一氧化氮合酶抑制引起的大鼠胸主动脉功能和形态变化的有益作用。

获取原文
获取原文并翻译 | 示例
       

摘要

The present study examined whether pentaerythrityl tetranitrate (PETN), a tolerance-devoid exogenous donor of nitric oxide (NO), could attenuate functional and morphological changes in the rat thoracic aorta evoked by 6-week NO synthase inhibition by NG-nitro-L-arginine methyl ester (L-NAME). Systolic blood pressure in L-NAME + PETN-treated rats (163 +/- 1 mm Hg) was significantly lower than in L-NAME-treated rats (172 +/- 2 mm Hg) but was still higher than in age-matched controls (126 +/- 2 mm Hg). Six weeks of treatment of rats with L-NAME significantly inhibited endothelium-dependent relaxation of the isolated thoracic aorta induced by acetylcholine. The inhibitory effect of L-NAME was entirely reversed by the simultaneous treatment with PETN. The enhancing effect of L-NAME on noradrenaline-induced contraction was antagonised by long-term treatment with PETN. Wall thickness, cross-sectional area and wall/diameter ratio of the thoracic aorta in L-NAME-treated rats were markedly increased. In the L-NAME + PETN-treated rats, the increment of these parameters was significantly lower. The results suggest that PETN administered to rats during development of NO-deficient hypertension prevented functional impairment and at the same time reduced structural changes in the thoracic aorta induced by long-term inhibition of NO synthase.
机译:本研究检查了季戊四醇四硝酸盐(PETN)(无耐受性的一氧化氮外源供体)是否可以减弱NG-硝基-L-抑制6周NO合酶诱发的大鼠胸主动脉的功能和形态变化。精氨酸甲酯(L-NAME)。 L-NAME + PETN治疗的大鼠(163 +/- 1 mm Hg)的收缩压显着低于L-NAME治疗的大鼠(172 +/- 2 mm Hg),但仍高于年龄匹配的大鼠控制(126 +/- 2毫米汞柱)。用L-NAME处理大鼠六周后,乙酰胆碱诱导的离体胸主动脉内皮依赖性舒张受到明显抑制。同时使用PETN治疗可完全逆转L-NAME的抑制作用。 PETN长期治疗可拮抗L-NAME对去甲肾上腺素诱导的收缩的增强作用。 L-NAME处理的大鼠的胸主动脉壁厚度,横截面积和壁/直径比显着增加。在L-NAME + PETN治疗的大鼠中,这些参数的增加明显较低。结果表明,在NO缺乏型高血压发展过程中向大鼠施用PETN可以防止功能受损,同时减少了长期抑制NO合酶诱导的胸主动脉的结构变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号